Relay Therapeutics, Inc. (RLAY)

Last Closing Price: 3.42 (2025-08-13)

Company Description

Relay Therapeutics Inc. is a clinical-stage precision medicines company. It focuses on enhancing small molecule therapeutic discovery in targeted oncology. The company's product pipeline consist RLY-1971, RLY-4008 and RLY-PI3K1047 which are in clinical stage. Relay Therapeutics Inc. is based in Cambridge, Massachusetts.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $10.01M
Net Income (Most Recent Fiscal Year) $-337.71M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.86
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -3728.45%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -41.49%
Return on Assets (Trailing 12 Months) -37.43%
Current Ratio (Most Recent Fiscal Quarter) 20.92
Quick Ratio (Most Recent Fiscal Quarter) 20.92
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $3.86
Earnings per Share (Most Recent Fiscal Quarter) $-0.41
Earnings per Share (Most Recent Fiscal Year) $-2.36
Diluted Earnings per Share (Trailing 12 Months) $-1.95
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 172.41M
Free Float 164.01M
Market Capitalization $577.58M
Average Volume (Last 20 Days) 3.06M
Beta (Past 60 Months) 1.62
Percentage Held By Insiders (Latest Annual Proxy Report) 4.87%
Percentage Held By Institutions (Latest 13F Reports) 96.98%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%